Telomere maintenance in telomerase‐positive human ovarian SKOV‐3 cells cannot be retarded by complete inhibition of telomerase

[1]  J. Au,et al.  Telomere Amount and Length Assay , 2001, Pharmaceutical Research.

[2]  Jie Lu,et al.  A Quantitative Assay of Telomerase Activity , 2001, Pharmaceutical Research.

[3]  M. Pardue,et al.  Structure of the Drosophila HeT-A transposon: a retrotransposon-like element forming telomeres , 1994, Chromosoma.

[4]  R. Reddel,et al.  Alternative Lengthening of Telomeres in Human Cells , 2001, Radiation research.

[5]  A. Godwin,et al.  ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle. , 2000, Journal of cell science.

[6]  R. Reddel,et al.  Telomere maintenance by recombination in human cells , 2000, Nature Genetics.

[7]  Rachel L. Allen,et al.  Defying death after DNA damage , 2000, Nature.

[8]  V. Lundblad,et al.  DNA ends: maintenance of chromosome termini versus repair of double strand breaks. , 2000, Mutation research.

[9]  M. Daidone,et al.  Inhibition of telomerase activity by a cell‐penetrating peptide nucleic acid construct in human melanoma cells , 2000, FEBS letters.

[10]  M. Daidone,et al.  Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells. , 2000, The Journal of investigative dermatology.

[11]  E. Blackburn,et al.  Ku is associated with the telomere in mammals. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  W. Hahn,et al.  Inhibition of telomerase limits the growth of human cancer cells , 1999, Nature Medicine.

[13]  T. Petes,et al.  Interactions of TLC1 (Which Encodes the RNA Subunit of Telomerase), TEL1, and MEC1 in Regulating Telomere Length in the Yeast Saccharomyces cerevisiae , 1999, Molecular and Cellular Biology.

[14]  R. Reddel,et al.  Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. , 1999, Cancer research.

[15]  M. Hande,et al.  Telomere Length Dynamics and Chromosomal Instability in Cells Derived from Telomerase Null Mice , 1999, The Journal of cell biology.

[16]  W. Hahn,et al.  Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Benchimol,et al.  Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span , 1998, Current Biology.

[18]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[19]  R. Reddel,et al.  Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines , 1997, Nature Medicine.

[20]  H. Biessmann,et al.  Chromosome end elongation by recombination in the mosquito Anopheles gambiae , 1997, Molecular and cellular biology.

[21]  H. Biessmann,et al.  Telomere maintenance without telomerase. , 1997, Chromosoma.

[22]  E. Blackburn,et al.  Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines , 1996, Molecular and cellular biology.

[23]  V A Zakian,et al.  Telomeres: Beginning to Understand the End , 1995, Science.

[24]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[25]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[26]  E. Blackburn,et al.  An alternative pathway for yeast telomere maintenance rescues est1− senescence , 1993, Cell.

[27]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[28]  T. Petes,et al.  Identification of yeast mutants with altered telomere structure. , 1986, Proceedings of the National Academy of Sciences of the United States of America.